Ranq Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 27-12-2024
- Paid Up Capital ₹ 0.50 M
as on 27-12-2024
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 22.00 Cr
as on 27-12-2024
- Revenue 27.00%
(FY 2023)
- Profit 425.95%
(FY 2023)
- Ebitda 37.91%
(FY 2023)
- Net Worth 6.94%
(FY 2023)
- Total Assets 4.94%
(FY 2023)
About Ranq Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹22.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Janhavi Jangle and Sameer Ranadive serve as directors at the Company.
- CIN/LLPIN
U24230MH2002PTC137303
- Company No.
137303
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ranq Remedies Private Limited offer?
Ranq Remedies Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Pharmaceutical Excipients.
Who are the key members and board of directors at Ranq Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Janhavi Jangle  | Director | 18-Jul-2013 | Current |
| Sameer Ranadive | Director | 20-Sep-2002 | Current |
Financial Performance of Ranq Remedies.
Ranq Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27% increase. The company also saw a substantial improvement in profitability, with a 425.95% increase in profit. The company's net worth moved up by a moderate rise of 6.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ranq Remedies?
In 2023, Ranq Remedies had a public holding of 90.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ranq Pharmaceuticals And Excipients Private LimitedActive 33 years 5 monthsJanhavi Jangle and Sameer Ranadive are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda (Senapati Bapat Road Branch) Creation Date: 11 Feb 2015 | ₹22.00 Cr | Satisfied |
How Many Employees Work at Ranq Remedies?
Ranq Remedies has a workforce of 52 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ranq Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranq Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
